RGEN
NASDAQ · Life Sciences Tools & Services
Repligen Corp
$186.75
+6.04 (+3.34%)
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Price Target
Analyst Price Target
-66.7% upside
Low Target
$40.44
Average Target
$62.10
High Target
$74.58
Current Price
$186.75
Current
$186.75
$186.75
Target
$62.10
$62.10
$40.44
$62.10 avg
$74.58
Scenario Analysis
Bear Case
$40.44
-78.3%
Low target
Base Case
$62.10
-66.7%
Avg target
Bull Case
$74.58
+-60.1%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$188.73
-1.0% from high
52-Week Low
$100.99
+84.9% from low
50-Day SMA
$157.63
+18.5% vs SMA
200-Day SMA
$139.06
+34.3% vs SMA
RSI (14)
28.0
Oversold
Target vs 52W High
$62.10
-67.1% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 36 | 81% | $369.21 | -43.9% |
| DHR | Strong Buy | 32 | 84% | $158.11 | -28.5% |
| IQV | Strong Buy | 28 | 82% | $82.96 | -69.3% |
| A | Strong Buy | 30 | 77% | $64.69 | -61.3% |
| WAT | Buy | 31 | 65% | $189.60 | -55.5% |
| ILMN | Buy | 28 | 57% | $169.36 | -31.6% |
| MTD | Hold | 19 | 53% | $170.43 | -88.6% |
| WST | Strong Buy | 23 | 91% | $136.24 | -63.3% |